RxDoctor Payments Data

Christian Bime, MD

Pulmonary Disease · Tucson, AZNPI 1952507279

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,400 of the $9,519 with a category attached, or 98.7%. Penumbra, Inc. accounts for 98.7% of it on its own, with 1 other manufacturer making up the rest.

$9,519in general payments, 2019–2025

Across 3 payments — averaging $3173.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$9K
  • Merit Medical Systems Inc$119
$165,555in research payments, 2019–2025

Across 45 payments — averaging $3679.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$110K
  • Dompe Farmaceutici S.p.a.$56K

What the payments were for

  • Consulting fees$9,40099%
  • Food & beverage$1191%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.2$9,400
Merit Medical Systems Inc1$119

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,519 in reported general payments places this provider in the 75th percentile of 250 pulmonary disease providers in Arizona.

See all pulmonary disease providers in Arizona

Medicare billing

Part B allowed, 2024
$26,650
Medicare patients
87
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →